Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells

American Journal of Physiology - Endocrinology and Metabolism

Volumn 298, Issue 1, 2010, Pages

  Chen, Shali ^a   Feng, Biao ^a   George, Biju ^a   Chakrabarti, Rana ^a   Chen, Megan ^a   Chakrabarti, Subrata ^a  

^a WESTERN UNIVERSITY   (Canada)

Author keywords

Transcription factors; Vasoactive factors

Indexed keywords

CURCUMIN; ENDOTHELIN 1; FIBRONECTIN; GLUCOSE; HISTONE ACETYLTRANSFERASE PCAF; HISTONE H2AX; LYSINE; SCLEROPROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; ENDOTHELIUM CELL; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; TRANSCRIPTION INITIATION; UMBILICAL VEIN; UPREGULATION; VASCULAR TISSUE;

ACETYLATION; ANIMALS; AORTA; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; DIABETES COMPLICATIONS; DNA DAMAGE; ENDOTHELIAL CELLS; ENDOTHELIN-1; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION; GLUCOSE; HISTONES; HUMANS; HYPERGLYCEMIA; MALE; ORGAN CULTURE TECHNIQUES; P300-CBP TRANSCRIPTION FACTORS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; RNA, SMALL INTERFERING; UMBILICAL VEINS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 73649093379     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00432.2009     Document Type: Article

References (55)

1. Arias J, Alberts AS, Brindle P, Claret FX, Smeal T, Karin M. Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature 370: 226-229, 1994.
2. Avantaggiati ML, Carbone M, Graessmann A, Nakatani Y, Howard B, Levine AS. The SV40 large T antigen and adenovirus E1a oncoproteins interact with distinct isoforms of the transcriptional co-activator, p300. EMBO J 15: 2236-2248, 1996.
3. Bannister AJ, Kouzarides T. The CBP co-activator is a histone acetyltransferase. Nature 384: 641-643, 1996.
4. Boyes J, Byfield P, Nakatani Y, Ogryzko V. Regulation of activity of the transcription factor GATA-1 by acetylation. Nature 396: 594-598, 1998.
5. Brivanlou AH, Darnell JE. Signal transduction and the control of gene expression. Science 295: 813-818, 2002.
6. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820, 2001.
7. Chen LF, Greene WC. Regulation of distinct biological activities of the NF-kappaB transcription factor complex by acetylation. J Mol Med 81: 549-557, 2003.
8. Chen S, Evans T, Deng D, Cukiernik M, Chakrabarti S. Hyperhexosemia induced functional and structural changes in the kidneys: role of endothelins. Nephron 90: 86-94, 2002.
9. Chen S, Khan ZA, Cukiernik M, Chakrabarti S. Differential activation of NF-kappaB and AP-1 in increased fibronectin synthesis in target organs of diabetic complications. Am J Physiol Endocrinol Metab 284: E1089-E1097, 2003.
10. Chen S, Mukherjee S, Chakrabarti S. Glucose-induced endothelindependent increased extracellular matrix protein synthesis is mediated via NF-κB and AP-1. Am J Physiol Cell Physiol 284: C263-C272, 2003.
11. Chiu J, Khan ZA, Farhangkhoee H, Chakrabarti S. Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-kappaB. Nutrition 25: 964-972, 2009.
12. Cukiernik M, Hileeto D, Evans T, Mukherjee S, Downey D, Chakrabarti S. Vascular endothelial growth factor in diabetes induced early retinal abnormalities. Diabetes Res Clin Pract 65: 197-208, 2004.
13. Deng D, Evans T, Mukherjee K, Downey D, Chakrabarti S. Diabetesinduced vascular dysfunction in the retina: role of endothelins. Diabetologia 42: 1228-1234, 1999.
14. Deng W, Wu K. Regulation of inducible nitric oxide synthase expression by p300 and p50 acetylation. J Immunol 171: 6581-6588, 2003.
15. Evans T, Deng DX, Chakrabarti S. Endothelin receptor blockade prevents augmented extracellular matrix protein component mRNA expression and capillary basement membrane thickening in the retina of diabetic and galactose fed rats. Diabetes 49: 662-666, 2000.
16. Farhangkhoee H, Khan ZA, Chen S, Chakrabarti S. Differential effects of curcumin on vasoactive factors in the diabetic rat heart. Nutr Metab 3: 27-34, 2006.
17. Feng B, Chen S, Chiu J, Chakrabarti S. Regulation of cardiomyocyte hypertrophy in diabetes. Am J Physiol Endocrinol Metab 294: E1119-E1126, 2008.
18. Fischle W, Wang Y, Allis CD. Histone and chromatin cross-talk. Curr Opin Cell Biol 15: 172-183, 2003.
19. Giordano A, Avantaggiati ML. p300 and CBP: partners for life and death. J Cell Physiol 181: 218-230, 1999.
20. Goel A, Jhurani S, Aggarwal BB. Multi-targeted therapy by curcumin: how spicy is it? Mol Nutr Food Res 52: 1010-1030, 2008.
21. Goodman RH, Smolik S. CBP/p300 in cell growth, transformation, and development. Genes Dev 14: 1553-1577, 2000.
22. Han J, Molkentin JD. Regulation of MEF2 by p38 MAPK and its implication in cardiomyocyte biology. Trends Cardiovasc Med 10: 19-22, 2000.
23. Hansmann G, Vinicio A, Perez VA, Alastalo TP, Alvira CM, Guignabert C, Bekker JM, Schellong S, Urashima T, Wang L, Morrell NW, Rabinovitch M. An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension. J Clin Invest 118: 1846-1857, 2008.
24. Hassa PO, Haenni SS, Buerki C, Meier NI, Lane WS, Owen H, Gersbach M, Imhof R, Hottiger MO. Acetylation of poly(ADP-ribose) polymerase-1 by p300/CREB-binding protein regulates coactivation of NF-kappaB-dependent transcription. J Biol Chem 280: 40450-40464, 2005.
25. Huber LC, Distler JH, Moritz F, Hemmatazad H, Hauser T, Michel BA, Gay RE, Matucci-Cerinic M, Gay S, Distler O, Jungel A. Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis. Arthritis Rheum 56: 2755-2764, 2007.
26. Janknecht R. The versatile functions of the transcriptional coactivators p300 and CBP and their roles in disease. Histol Histopathol 17: 657-668, 2002.
27. Kalkhoven E. CBP and p300: HATs for different occasions. Biochem Pharmacol 68: 1145-1155, 2004.
28. Kaur H, Chen S, Xin X, Chiu J, Khan ZA, Chakrabarti S. Diabetesinduced extracellular matrix protein expression is mediated by transcription co-activator p300. Diabetes 55: 3104-3111, 2006.
29. Khan ZA, Chan BM, Uniyal S, Barbin YP, Farhangkhoee H, Chen S, Chakrabarti S. EDB fibronectin and angiogenesis-a novel mechanistic pathway. Angiogenesis 8: 183-196, 2005.
30. Khan ZA, Cukiernik M, Gonder JR, Chakrabarti S. Oncofetal fibronectin in diabetic retinopathy. Invest Ophthalmol Vis Sci 45: 287-295, 2004.
31. Khan ZA, Farhangkhoee H, Chakrabarti S. Towards newer molecular targets for chronic diabetic complications. Curr Vasc Pharmacol 4: 45-57, 2006.
32. King GL, Brownlee M. The cellular and molecular mechanisms of diabetic complications. Endocrinol Metab Clin North Am 25: 255-270, 1996.
33. Kowluru RA, Kanwar M. Effects of curcumin on retinal oxidative stress and inflammation in diabetes. Nutr Metab (Lond) 4: 8, 2007.
34. Lodewick J, Lamsoul I, Polania A, Lebrun S, Burny A, Ratner L, Bex F. Acetylation of the human T-cell leukemia virus type 1 Tax oncoprotein by p300 promotes activation of the NF-kappaB pathway. Virology 386: 68-78, 2009.
35. Ma K, Chan JK, Zhu G, Wu Z. Myocyte enhancer factor 2 acetylation by p300 enhances its DNA binding activity, transcriptional activity, and myogenic differentiation. Mol Cell Biol 25: 3575-3582, 2005.
36. Marcu MG, Jung YJ, Lee S. Curcumin is an inhibitor of p300 histone acetylatransferase. Med Chem 2: 169-174, 2006.
37. McKinsey TA, Olson EN. Cardiac histone acetylation-therapeutic opportunities abound. Trends Genet 20: 206-213, 2004.
38. McKinsey TA, Olson EN. Toward transcriptional therapies for the failing heart: chemical screens to modulate genes. J Clin Invest 115: 538-546, 2005.
39. Merrick AF, Shewring LD, Cunningham SA, Gustafsson K, Fabre JW. Organ culture of arteries for experimental studies of vascular endothelium in situ. Transpl Immunol 5: 3-9, 1997.
40. Miao F, Gonzalo IG, Lanting L, Natarajan R. In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions. J Biol Chem 279: 18091-18097, 2004.
41. Morimoto T, Sunagawa Y, Kawamura T, Takaya T, Wada H, Nagasawa A, Komeda M, Fujita M, Shimatsu A, Kita T, Hasegawa K. The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. J Clin Invest 118: 868-878, 2008.
42. Nan B, Lin P, Lumsden AB, Yao Q, Chen C. Effects of TNF-alpha and curcumin on the expression of thrombomodulin and endothelial protein C receptor in human endothelial cells. Thromb Res 115: 417-426, 2005.
43. Redon C, Pilch D, Rogakou E, Sedelnikova O, Newrock K, Bonner W. Histone H2A variants H2AX and H2AZ. Curr Opin Genet Dev 12: 162-169, 2002.
44. Roy S, Cagliero E, Lorenzi M. Fibronectin overexpression in retinal microvessels of patients with diabetes. Invest Ophthalmol Vis Sci 37: 258-266, 1996.
45. Rozengurt E, Rey O, Waldron RT. Protein kinase D signaling. J Biol Chem 280: 13205-13208, 2005.
46. Sheetz MJ, King GL. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 288: 2579-2588, 2002.
47. Shurin GV, Ferris R, Tourkova IL, Perez L, Lokshin A, Balkir L, Collins B, Chatta GS, Shurin MR. Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo. J Immunol 174: 5490-5498, 2005.
48. Siperstein MD, Unger RH, Madison LL. Studies of muscle capillary basement membranes in normal subjects, diabetic, and prediabetic patients. J Clin Invest 47: 1973-1999, 1968.
49. Williamson JR, Tilton RG, Chang K, Kilo C. Basement membrane abnormalities in diabetes mellitus: relationship to clinical microangiopathy. Diabetes Metab Rev 4: 339-370, 1988.
50. Xin X, Khan ZA, Chen S, Chakrabarti S. Extracellular signal-regulated kinase (ERK) in glucose-induced and endothelin-mediated fibronectin synthesis. Lab Invest 84: 1451-1459, 2004.
51. Xu B, Chiu J, Feng B, Chen S, Chakrabarti S. PARP activation and the alteration of vasoactive factors and extracellular matrix protein in retina and kidney in diabetes. Diabetes Metab Res Rev 24: 404 - 412, 2008.
52. Yamashita K, Discher DJ, Hu J, Bishopric NH, Webster KA. Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, and p300/CBP. J Biol Chem 276: 12645-12653, 2001.
53. Yanazume T, Morimoto T, Wada H, Kawamura T, Hasegawa K. Biological role of p300 in cardiac myocytes. Mol Cell Biochem 248: 115-119, 2003.
54. Zhang CL, McKinsey TA, Chang S, Antos CL, Hill JA, Olson EN. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110: 479-488, 2002.
55. Zhong H, May MJ, Jimi E, Ghosh S. The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell 9: 625-636, 2002.